Defining Appropriate and Effective Interactions with Thought Leaders and KOLs

PHARMA MARKETING NEWS AD SUPPLEMENT
16 September 2010

Greetings!

Pharma Marketing News is proud to be a Media Partner for this conference. Thanks to CBI for offering our readers a discount! See below for details.

John Mack, Editor
editor@news.pharma-mkting.com

- Special Offer for Pharma Marketing News Subscribers -
Save $400 off of the standard registration rate*
(mention promotional code CTZ322)
<< Register Now! >>

REQUEST BROCHURE

VIEW WEBSITE

REFER COLLEAGUES

Conference Chairman:

Jeffrey Humphrey, Vice President, U.S. Medical Strategy, Oncology,
Bristol-Myers Squibb

Industry Insights from:

Anne Baker, Former Vice President, Legal and Regulatory Affairs, General Counsel,Coloplast Corp.

Mark Bechter, Global Medical Director,Baxter Healthcare

Katrina Cahill, Business Process Consultant,Genzyme Corporation

Anton Ehrhardt, Senior Medical Director, Global Medical Affairs,Millennium: The Takeda Oncology Company

Heidi Gautier, Vice President, Cardiovascular Market Development,Genzyme Corporation

Linda Harris, Vice President, Thought Leader Strategies, Nexus Communications; Former Assistant Vice President OL Relations, Wyeth Pharmaceuticals

Scott Kraun, Director, Professional Relations and Education,Given Imaging, Inc.

Suzanne Maslow, Senior Brand Manager,Novo Nordisk Inc.

Lisa Miller, Executive Director, Healthcare Education and Liaison Programs,Purdue Pharma L.P.

Sheila Murphy, Group Marketing Manager, Global Marketing, Baxter Healthcare

Erica Owen, Principal Business Process Analyst,Genzyme Corporation

Kathy Presto, Vice President, Strategic Partnerships, Roche Pharmaceuticals

Tim Schuh, Associate Brand Director, Diabetes Marketing, Novo Nordisk Inc.

Paul Weber, Head, Medical Affairs,PTC Therapeutics

Benefit from Comprehensive Guidance Coverage:

State Requirements Analysis
Arthur Corrado, Founder and Principal, Pharmaceutical Compliance Associates, LLC.; Former Wyeth Senior Compliance Officer, Pfizer Inc

Academic Medical Center Conflict-of-Interest Guidance Changes
Guy Chisolm, Vice Chair, Lerner Research Institute of Cleveland Clinic

Gain Critical Expertise for Compliant and Dynamic KOL Management:

Collaborate internally to align KOL expertise with business needs throughout the product lifecycle
Satisfy commercial goals without generating negative press or distancing KOLs
Design and execute a global KOL strategy
Learn how a KOL relationship focused on disease management sets the stage for commercial success
Develop FMV strategy and understand tactics to establish ranges

PLUS! Choose from Two Pre-Conference Workshops — Wednesday, November 3, 2010:

A. Develop a Centralized KOL Management Model — Assess the Need and Understand Best Practices for Implementation

B. Establish the Framework for an Opinion Leader (OL) Management System

Outstanding Support Provided by:

REQUEST BROCHURE

VIEW WEBSITE

REFER COLLEAGUES

- Special Offer for Pharma Marketing News Subscribers -
Save $400 off of the standard registration rate*
(mention promotional code CTZ322)
<< Register Now! >>

2010 Executive Sponsor:

2010 Sponsors:

*Discount offer can not be combined with other discounts or applied to a current registration.
Offer not valid on workshop only or academic registrations.

www.cbinet.com/KOL | 800-817-8601 | cbireg@cbinet.com

# # #

You are subscribed to Pharma Marketing News, which is published by:

VirSci Corporation
PO Box 760
Newtown, PA 18940-0760
infovirsci@virsci.com

CHANGING YOUR SUBSCRIPTION OPTIONS
You are receiving this message as a valued reader of Pharma Marketing News. We are committed to protecting the privacy of our readers. We do not disclose or distribute our email subscription list to any third party, nor permit anyone else to do so.

If you wish to unsubscribe from Pharma Marketing News, please click the "SafeUnsubscribe" button below. You can also send an email request to unsubscribe@news.pharma-mkting.com.

PHARMA MARKETING NEWS AD POLICY
Our policy allows relevant paid promotional messages (Ads) to be emailed to subscribers, who have opted in to receive such messages as a condition for a free subscription to Pharma Marketing News.

All ads are approved by the Editor and are sent by the Editor on behalf of our advertisers. Only a limited number of ads deemed relevant to subscribers are accepted. The subject line of each email ad accurately reflects the content of the ad. At any time you have the option to cancel your subscription and stop receiving these ads (see CHANGING YOUR SUBSCRIPTION OPTIONS, above).

If you are interested in placing an ad in Pharma Marketing News, please find more information on the Pharma Marketing Network Advertising Information Page, call 215-504-4164, or email sales@pharma-mkting.com

CONTRIBUTE ARTICLES
Do you wish to contribute an article? E-mail the editor of Pharma Marketing News, at editor@news.pharma-mkting.com. Please see Author Guidelines for instructions.